
Cantabio Pharmaceuticals
Cantabio Pharmaceuticals is focused on bringing novel, first-in-class drug candidates and diagnostics into clinical trials and beyond for Parkinson’s, Alzheimer and Diabetic Kidney diseases through the discovery and development of innovative pharmacological chaperone and protein delivery-based therapeutics aimed at addressing the reduction of biochemical stress such as protein aggregation, oxidative and glyoxal stress, the root causes of various diseases.